Biosynex (ALBIO) — Cash Flow-to-Debt Ratio
Latest as of June 2025:
-0.07x
Biosynex (ALBIO) has a Cash Flow-to-Debt Ratio of -0.07x as of June 2025, meaning its operating cash flow of €-7.07 Million could theoretically repay 0% of its total liabilities (€105.13 Million) in one year. See ALBIO FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
-0.07x
Operating CF / Total Liabilities
Operating Cash Flow
€-7.07 Million
EUR
Total Liabilities
€105.13 Million
EUR
Data as of
Jun 2025
Most recent filing
Biosynex Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for Biosynex across 12 annual periods. Also explore Biosynex annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Biosynex (2008–2024)
Year-by-year debt coverage analysis for Biosynex. For market capitalisation and broader financial context, see how much is Biosynex worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.09x | €-10.12 Million | €114.19 Million | ▼ -7.8% |
| 2023 | -0.08x | €-9.65 Million | €117.41 Million | ▼ -255.0% |
| 2022 | 0.05x | €4.95 Million | €93.21 Million | ▼ -95.1% |
| 2021 | 1.09x | €109.83 Million | €101.14 Million | ▲ +105.2% |
| 2020 | 0.53x | €31.64 Million | €59.78 Million | ▲ +713.2% |
| 2019 | 0.07x | €1.10 Million | €16.97 Million | ▲ +42.1% |
| 2018 | 0.05x | €467.12K | €10.20 Million | ▲ +9.6% |
| 2017 | 0.04x | €484.82K | €11.60 Million | ▲ +29.2% |
| 2016 | 0.03x | €489.91K | €15.15 Million | ▼ -52.2% |
| 2015 | 0.07x | €461.66K | €6.82 Million | ▼ -9.7% |
| 2009 | 0.07x | €72.40K | €965.95K | ▲ +129.7% |
| 2008 | -0.25x | €-184.44K | €731.01K | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.